From OMIMBy convention, the designation CMT4 is applied to autosomal recessive forms of demyelinating Charcot-Marie-Tooth disease, which is a peripheral neuropathy characterized by distal motor and sensory impairment resulting in gait difficulties and associated with foot deformities. Motor nerve conduction velocities are decreased, and sural nerve biopsies show loss of myelinated fibers. The age at onset and severity is variable (summary by Patzko and Shy, 2012).
Genetic Heterogeneity of Charcot-Marie-Tooth Disease Type 4
Several different subtypes of autosomal recessive demyelinating CMT (CMT4) have been identified, each with particular ethnic, pathologic, or clinical characteristics: CMT4A; CMT4B, which includes CMT4B1 (601382), caused by mutation in the MTMR2 gene (603557), CMT4B2 (604563), caused by mutation in the SBF2 gene (607697), and CMT4B3 (615284), caused by mutation in the SBF1 gene (603560); CMT4C (601596), caused by mutation in the SH3TC2 gene (608206); CMT4D (601455), caused by mutation in the NDRG1 gene (605262); CMT4E (605253), caused by mutation in the EGR2 (129010) or MPZ (159440) genes; CMT4F (614895), caused by mutation in the PRX gene (605725); CMT4G, or Russe-type hereditary motor and sensory neuropathy, (605285), which maps to chromosome 10q23; CMT4H (609311), caused by mutation in the FGD4 gene (611104); CMT4J (611228), caused by mutation in the FIG4 gene (609390); and CMT4K (616684), caused by mutation in the SURF1 gene (185620).
http://www.omim.org/entry/214400